CYAD

Celyad Oncology (CYAD)

Celyad Oncology SA

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:CYAD

1 2 3 4 5 6 7 8 9 10 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2024/04/04	14 : 00	Business Wire	Celyad Oncology publie ses résultats financiers pour l'année 2023 ainsi que les récents évènements marquants	NASDAQ:CYAD	Celyad Oncology SA
2024/04/04	14 : 00	Business Wire	Celyad Oncology Reports Full Year 2023 Financial Results and Recent Business Highlights	NASDAQ:CYAD	Celyad Oncology SA
2024/02/09	06 : 01	Business Wire	Celyad Oncology annonce son intention de mettre fin à ses obligations de déclaration à la SEC	NASDAQ:CYAD	Celyad Oncology SA
2024/02/09	06 : 01	Business Wire	Celyad Oncology Announces Intention to Terminate SEC Reporting Obligations	NASDAQ:CYAD	Celyad Oncology SA
2024/01/17	20 : 33	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:CYAD	Celyad Oncology SA
2024/01/17	06 : 01	Business Wire	Celyad Oncology Provides Fourth Quarter 2023 Business Update and 2024 Outlook	NASDAQ:CYAD	Celyad Oncology SA
2024/01/17	06 : 01	Business Wire	Celyad Oncology fait le point sur les activités du quatrième trimestre 2023 et présente ses perspectives pour 2024	NASDAQ:CYAD	Celyad Oncology SA
2023/12/21	20 : 19	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:CYAD	Celyad Oncology SA
2023/12/21	06 : 01	Business Wire	Celyad Oncology SA: Publication of a Transparency Notification Received From Fortress Investment Group LLC	NASDAQ:CYAD	Celyad Oncology SA
2023/12/21	06 : 01	Business Wire	Celyad Oncology SA : Publication d’une notification de transparence de Fortress Investment Group LLC	NASDAQ:CYAD	Celyad Oncology SA
2023/12/16	06 : 01	Business Wire	Celyad Oncology: Information on the Total Number of Voting Rights and Shares (Article 15 of the Law of 2 May 2007)	NASDAQ:CYAD	Celyad Oncology SA
2023/12/16	06 : 01	Business Wire	Celyad Oncology SA : Information relative au Nombre Total de Droits de Vote et d’Actions (Article 15 de la Loi du 2 Mai 2007)	NASDAQ:CYAD	Celyad Oncology SA
2023/12/04	22 : 34	Business Wire	Celyad Announces Management Change	NASDAQ:CYAD	Celyad Oncology SA
2023/12/04	22 : 34	Business Wire	Celyad annonce un changement de direction	NASDAQ:CYAD	Celyad Oncology SA
2023/12/01	06 : 01	Business Wire	Celyad Oncology SA : Publication d’une notification de transparence reçue de Tolefi SA (Article 14 §1 de la loi du 2 mai 2007)	NASDAQ:CYAD	Celyad Oncology SA
2023/12/01	06 : 01	Business Wire	Celyad Oncology SA: Publication of a transparency notification received from Tolefi SA (Article 14 §1 of the Law of 2 May 2007)	NASDAQ:CYAD	Celyad Oncology SA
2023/11/22	06 : 00	Business Wire	Celyad Oncology SA : Publication d’une notification de transparence de Fortress Investment Group LLC	NASDAQ:CYAD	Celyad Oncology SA
2023/11/22	06 : 00	Business Wire	Celyad Oncology SA: Publication of a transparency notification received from Fortress Investment Group LLC	NASDAQ:CYAD	Celyad Oncology SA
2023/11/16	06 : 37	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:CYAD	Celyad Oncology SA
2023/11/15	06 : 00	Business Wire	Celyad Oncology: Information on the Total Number of Voting Rights and Shares (Article 15 of the Law of 2 May 2007)	NASDAQ:CYAD	Celyad Oncology SA
2023/11/15	06 : 00	Business Wire	Celyad Oncology SA : Information relative au Nombre Total de Droits de Vote et d’Actions (Article 15 de la Loi du 2 Mai 2007)	NASDAQ:CYAD	Celyad Oncology SA
2023/11/09	15 : 00	Business Wire	Celyad Oncology publie ses résultats financiers pour le troisième trimestre de 2023 ainsi que ses récentes avancées	NASDAQ:CYAD	Celyad Oncology SA
2023/11/09	15 : 00	Business Wire	Celyad Oncology reports third quarter 2023 financial results and recent business highlights	NASDAQ:CYAD	Celyad Oncology SA
2023/10/28	02 : 45	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:CYAD	Celyad Oncology SA
2023/09/26	05 : 01	Business Wire	Celyad Oncology Announces the Termination of Its American Depository Receipt Program	NASDAQ:CYAD	Celyad Oncology SA
2023/09/26	05 : 01	Business Wire	Celyad Oncology annonce l’arrêt de son programme d’American Depositary Receipt	NASDAQ:CYAD	Celyad Oncology SA
2023/09/18	19 : 04	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:CYAD	Celyad Oncology SA
2023/09/16	05 : 01	Business Wire	Celyad Oncology SA : Publication d’une notification de transparence rectifiée de Fortress Investment Group LLC	NASDAQ:CYAD	Celyad Oncology SA
2023/09/16	05 : 01	Business Wire	Celyad Oncology SA: Publication of a Rectified Transparency Notification Received From Fortress Investment Group LLC	NASDAQ:CYAD	Celyad Oncology SA
2023/09/13	19 : 29	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:CYAD	Celyad Oncology SA